Company intelligence / Profile preview

Lexington International

Boca Raton, Florida, United Stateshairmaxpro.com ↗

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Lexington International has developed and commercialized the HairMax LaserComb and related laser phototherapy devices for the treatment of hereditary hair loss. Their products have undergone seven clinical studies with 460 subjects, demonstrating efficacy and safety as first-line therapy for appropriate classes of hereditary hair loss. Over 93% of subjects in double-blind studies experienced hair growth at six months[1].

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Lexington International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lexington International.

Explore the full profile